Radiology Oncology Surgical Robot Devices Sector Could Reach USD 7.3 Billion by 2022

A new report has been published indicating that worldwide market for radiology oncology surgical robots market is growing mainly due to an aging world population, and the benefits the new technology can offer.

Radiology oncology surgical robot technology provides opportunities to change cancer treatment methods, including the increased use of stereotactic body radiosurgery, instead of surgery or other conventional treatments. Radiosurgery has the potential to revolutionize cancer treatment by removing tumors without damage to surrounding healthy tissue.

The report entitled "Radiology Oncology Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2016–2022" was published by Wintergreen Research (Lexington, MA, USA) and was made available by Research and Markets (Dublin, Ireland). Radiosurgery equipment providers mentioned in the report include Accuray (Sunnyvale, CA; USA), Brainlab (Munich, Germany), and ViewRay (Cleveland OH, USA).

The annual number new cancer cases diagnosed is forecast to increase to 20 million by 2025, from 14.9 million in 2015. Radiosurgery makes use of high radiation doses precisely eliminate tumors, and leaves healthy tissue unharmed. The demand and sales of this radiosurgery has increased profit margins for companies offering this technology during the last five years. Hospitals are also adopting the technology to improve outcomes.

Related Links:
Wintergreen Research
Research and Markets
Accuray